Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.08. | Actinogen Medical - Further positive XanaCIDD results on depression | 258 | Edison Investment Research | New data were revealed from Actinogen Medical's ongoing analysis of the now-completed XanaCIDD study that support the view that the company's lead drug candidate, Xanamem, may provide consistent and... ► Artikel lesen | |
27.08. | Mendus - Broad progress across the pipeline | 192 | Edison Investment Research | Mendus's Q224 results reflect a period of steady progress across its clinical programmes. For vididencel, the Phase II CADENCE trial (for acute myeloid leukaemia, AML) is now ready to commence patient... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.848 |
EVOTEC | 2.050 |
TUI | 1.737 |
BAYER | 1.687 |
NVIDIA | 1.599 |
NEL | 1.169 |
RENK GROUP | 1.078 |
RHEINMETALL | 993 |
TESLA | 838 |
PALANTIR TECHNOLOGIES | 785 |
DEUTSCHE BANK | 733 |
VOLKSWAGEN | 712 |
MICROSTRATEGY | 682 |
BYD | 658 |
PLUG POWER | 650 |
COMMERZBANK | 600 |
JINKOSOLAR | 594 |
BASF | 591 |
MERCEDES-BENZ | 567 |
AMAZON | 548 |
INTEL | 532 |
BMW | 525 |
HUGO BOSS | 522 |
DEUTSCHE TELEKOM | 521 |
THYSSENKRUPP | 507 |